4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001966716-25-000004
GENERAL COUNSEL & CORP SEC sold 10,000 shares at $25.07 ($250,650)
- GENERAL COUNSEL & CORP SEC acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-10-03 | Option exercise 10b5-1 | +10,000 | $9.15 | $91,500 | 21,831 | D |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-10-03 | Sale 10b5-1 | −10,000 | $25.07 | $250,650 | 11,831 | D |
| Derivatives | |||||||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-10-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 34,800 | D | ||
| Open-market sales · 10,000 sh · avg $25.07 · $250,650 | |||||||
Loading xslF345X05/form4-10072025_081001.xml…